Zhong Yuan Bio-Technology Holdings Limited
ZHYBF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.50 | -4.74 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.50% |
| EV / EBITDA | -831.08 | -346.24 | 935.45 | 204.27 |
| Quality | ||||
| ROIC | -4.66% | -4.64% | 3.61% | 15.78% |
| Gross Margin | 117.08% | 117.08% | 46.70% | 93.75% |
| Cash Conversion Ratio | – | – | – | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.16% | 10.98% | 12.52% | 22.60% |
| Free Cash Flow Growth | 0.00% | 0.00% | -100.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -22.20 | -22.40 | 23.88 | 5.86 |
| Interest Coverage | -543.17 | -543.17 | 0.00 | 30.83 |
| Efficiency | ||||
| Inventory Turnover | 2.01 | 2.01 | 2.98 | 0.68 |
| Cash Conversion Cycle | 424.13 | 248.76 | 227.91 | 252.65 |